Lindbrook Capital, LLC Incyte Corp Transaction History

Lindbrook Capital, LLC

$1.18 Billion
Q3 2024

A detailed history of Lindbrook Capital, LLC transactions in Incyte Corp stock. As of the latest transaction made, Lindbrook Capital, LLC holds 1,271 shares of INCY stock, worth $96,430. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,271

Previous 1,236 2.83%

Holding current value

$96,430

Previous $74,000 13.51%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$57.33 - $68.61 $2,006 - $2,401	35 Added 2.83%	1,271 $84,000
Q2 2024 Jul 31, 2024	SELL	$51.18 - $63.75 $16,275 - $20,272	-318 Reduced 20.46%	1,236 $74,000
Q1 2024 Apr 25, 2024	SELL	$56.55 - $66.59 $678 - $799	-12 Reduced 0.77%	1,554 $88,000
Q4 2023 Jan 31, 2024	BUY	$52.16 - $64.19 $44,231 - $54,433	848 Added 118.11%	1,566 $98,000
Q3 2023 Oct 25, 2023	BUY	$57.77 - $65.93 $6,585 - $7,516	114 Added 18.87%	718 $41,000
Q2 2023 Jul 28, 2023	SELL	$60.95 - $75.51 $1,462 - $1,812	-24 Reduced 3.82%	604 $37,000
Q1 2023 Apr 26, 2023	SELL	$70.23 - $86.01 $491 - $602	-7 Reduced 1.1%	628 $45,000
Q4 2022 Jan 24, 2023	SELL	$67.18 - $84.11 $4,366 - $5,467	-65 Reduced 9.29%	635 $0
Q3 2022 Nov 10, 2022	BUY	$66.18 - $82.86 $5,890 - $7,374	89 Added 14.57%	700 $47,000
Q2 2022 Aug 01, 2022	BUY	$66.18 - $83.18 $661 - $831	10 Added 1.66%	611 $46,000
Q1 2022 Apr 21, 2022	SELL	$66.02 - $79.71 $132 - $159	-2 Reduced 0.33%	601 $48,000
Q4 2021 Jan 18, 2022	BUY	$63.34 - $74.11 $32,556 - $38,092	514 Added 577.53%	603 $44,000
Q3 2021 Nov 05, 2021	BUY	$68.67 - $84.02 $3,433 - $4,201	50 Added 128.21%	89 $6,000
Q2 2021 Jul 27, 2021	BUY	$79.87 - $87.53 $1,837 - $2,013	23 Added 143.75%	39 $3,000
Q1 2021 Apr 28, 2021	SELL	$76.02 - $100.5 $836 - $1,105	-11 Reduced 40.74%	16 $1,000
Q4 2020 Jan 27, 2021	BUY	$80.74 - $97.7 $1,049 - $1,270	13 Added 92.86%	27 $2,000
Q3 2020 Nov 03, 2020	SELL	$85.07 - $109.69 $510 - $658	-6 Reduced 30.0%	14 $1,000
Q1 2020 Apr 22, 2020	SELL	$63.18 - $85.97 $4,864 - $6,619	-77 Reduced 79.38%	20 $1,000
Q4 2019 Jan 27, 2020	SELL	$73.04 - $95.72 $2,994 - $3,924	-41 Reduced 29.71%	97 $8,000
Q3 2019 Oct 31, 2019	BUY	$72.82 - $86.52 $2,548 - $3,028	35 Added 33.98%	138 $10,000
Q1 2019 Apr 23, 2019	SELL	$63.56 - $88.17 $2,161 - $2,997	-34 Reduced 24.82%	103 $8,000
Q4 2018 Feb 07, 2019	BUY	$58.5 - $69.94 $8,014 - $9,581	137 New	137 $8,000

Others Institutions Holding INCY

# of Institutions

641

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.9B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Incyte Corp Transaction History